$JNJ 4 SEC Filings

Filed On	Filing
10 Sep 2026	Form 4: Pinto Daniel E, Director Granted 113.098 Deferred Share Units ($31.3K)
10 Sep 2026	Form 4: Woods Eugene A., Director Granted 135.717 Deferred Share Units ($37.5K)
10 Sep 2026	Form 4: Hewson Marillyn A, Director Granted 180.956 Deferred Share Units ($50K)
04 Sep 2026	Form 4: Schmid Timothy, EVP, WW Chair, MedTech Received 33,597 shares by exercise or conversion ($4.87M) · Sold 33,597 shares ($9.23M)
18 Aug 2026	Form 4: Taubert Jennifer L, EVP, WWC. Innovative Medicine Received 15,000 shares by exercise or conversion ($1.74M) · Sold 15,000 shares ($3.95M)
14 Aug 2026	Form 4: Duato Joaquin, Director Received 123,291 shares by exercise or conversion ($14.3M) · Sold 123,291 shares ($32.2M)
07 Aug 2026	Form 4: Duato Joaquin, Director Sold 48,480 shares ($12.5M)
07 Aug 2026	Form 4: Forminard Elizabeth, EVP, Chief Legal Officer Received 9,344 shares by exercise or conversion ($1.23M) · Sold 15,918 shares ($4.09M)
21 Jul 2026	Form 4: Broadhurst Vanessa, EVP, Global Corp Affairs Received 23,054 shares by exercise or conversion ($3.01M) · Sold 23,054 shares ($5.79M)
12 Jun 2026	Form 4: Wengel Kathryn E, EVP, Chief TO and Risk Officer Received 10,000 shares by exercise or conversion ($1.16M) · Sold 10,000 shares ($2.41M)
11 Jun 2026	Form 4: Woods Eugene A., Director Granted 161.089 Deferred Share Units ($37.5K)
11 Jun 2026	Form 4: Pinto Daniel E, Director Granted 134.241 Deferred Share Units ($31.2K)
11 Jun 2026	Form 4: Hewson Marillyn A, Director Granted 214.786 Deferred Share Units ($50K)
04 May 2026	Form 4: Reed John C, EVP, Innovative Medicine, R&D Received 25,255 shares by exercise or conversion · Gave up 11,002 shares to cover exercise price or tax ($2.53M)
27 Apr 2026	Form 4: Woods Eugene A., Director Granted 975 Deferred Share Units
27 Apr 2026	Form 4: West Nadja, Director Granted 975 Deferred Share Units
27 Apr 2026	Form 4: Weinberger Mark A, Director Granted 975 Deferred Share Units
27 Apr 2026	Form 4: Pinto Daniel E, Director Granted 1,712 Deferred Share Units
27 Apr 2026	Form 4: Morikis John G, Director Granted 1,540 Deferred Share Units
27 Apr 2026	Form 4: McClellan Mark B., Director Granted 975 Deferred Share Units

Comments